ViraCor-IBT Laboratories Acquires Assets of Cylex, Inc.
2/6/2013 9:07:35 AM
More...
|
Cylex, Inc. Awarded New CPT Code For Its ImmuKnow(R) Assay
1/12/2010 10:55:59 AM
More...
|
Cylex, Inc. Appoints Brad L. Stewart as CEO
9/10/2009 9:33:19 AM
More...
|
Cylex, Inc.: Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
6/1/2009 9:25:38 AM
More...
|
Cylex, Inc. Release: An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
4/24/2009 12:23:52 PM
More...
|
Cylex, Inc. Receives ISO 13485:2003 and 9001:2000 Quality Certifications
10/2/2008 7:34:14 AM
More...
|
Sales Growth Spurs Cylex, Inc. to Expand Staff, Office Space
9/29/2008 7:53:01 AM
More...
|
Cylex, Inc. Patented ImmuKnow(R) Immune Cell Function Assay to be Studied in Italian Liver Transplant Patients
8/29/2008 6:49:19 AM
More...
|
Cylex, Inc. New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
8/22/2008 8:08:23 AM
More...
|
Cylex, Inc. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
8/22/2008 7:56:45 AM
More...
|
|